5151 - 5175 of 6451 Results
Title
Year
-
OPENTitle: RETRACTED: Development of Nonviral Vectors Targeting the Brain as a Therapeutic Approach For Parkinson's Disease and Other Brain DisordersJournal Name: Molecular TherapyPublisher: Elsevier BVVol: 24Issue #: 4Start Page: 746End Page: 758Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/mt.2015.232Best OA location URL: http://www.cell.com/article/S1525001616309984/pdfCitation Count: 41
-
OPENTitle: Differential cardiopulmonary monitoring system for artifact-canceled physiological tracking of athletes, workers, and COVID-19 patientsJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 7Issue #: 20Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1126/sciadv.abg3092Best OA location URL: https://doi.org/10.1126/sciadv.abg3092Citation Count: 109
-
OPENTitle: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic NeuronsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 75End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005Best OA location URL: http://www.cell.com/article/S2213671119304448/pdfCitation Count: 62
-
OPENTitle: Conopeptide-Functionalized Nanoparticles Selectively Antagonize Extrasynaptic N-Methyl-d-aspartate Receptors and Protect Hippocampal Neurons from Excitotoxicity In VitroJournal Name: ACS NanoPublisher: American Chemical Society (ACS)Vol: 14Issue #: 6Start Page: 6866End Page: 6877Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsnano.0c00866Best OA location URL: https://ndownloader.figstatic.com/files/22969427Citation Count: 16
-
OPENTitle: Unraveling the intersection of aging and Parkinson’s disease: a collaborative roadmap for advancing research modelsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page: 28End Page: 28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01239-xBest OA location URL: https://www.nature.com/articles/s41531-025-01239-x_reference.pdfCitation Count: 1
-
OPENTitle: Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 7Start Page: 919End Page: 927Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26170Best OA location URL: http://doi.org/10.1002/mds.26170Citation Count: 307
-
OPENTitle: α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathologyJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page: 74End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12974-016-0532-8Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-016-0532-8Citation Count: 35
-
OPENTitle: The effect of Apolipoprotein E4 on cognitive function in Parkinson’s disease: A structural MRI study in the PPMI cohortJournal Name: PLOS OnePublisher: Public Library of Science (PLoS)Vol: 21Issue #: 1Start Page: e0341240End Page: e0341240Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1371/journal.pone.0341240Best OA location URL: https://doi.org/10.1371/journal.pone.0341240Citation Count: 0
-
OPENTitle: Orientation selective deep brain stimulationJournal Name: Journal of Neural EngineeringPublisher: IOP PublishingVol: 14Issue #: 1Start Page: 016016End Page: 016016Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1088/1741-2552/aa5238Best OA location URL: http://doi.org/10.1088/1741-2552/aa5238Citation Count: 51
-
OPENTitle: Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 7Start Page: 879End Page: 880Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13021Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7533975Citation Count: 0
-
OPENTitle: Crystal structure of the WD40 domain dimer of LRRK2Journal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 116Issue #: 5Start Page: 1579End Page: 1584Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1073/pnas.1817889116Best OA location URL: https://www.pnas.org/content/pnas/116/5/1579.full.pdfCitation Count: 99
-
OPENTitle: Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease studyJournal Name: Contemporary Clinical TrialsPublisher: Elsevier BVVol: 115Issue #:Start Page: 106713End Page: 106713Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cct.2022.106713Best OA location URL: https://doi.org/10.1016/j.cct.2022.106713Citation Count: 20
-
OPENTitle: N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholineJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.97228.3Best OA location URL: https://doi.org/10.7554/elife.97228.3Citation Count: 6
- Smell status in functional movement disorders: New clues for diagnosis and underlying mechanisms2019OPENTitle: Smell status in functional movement disorders: New clues for diagnosis and underlying mechanismsJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 177Issue #:Start Page: 68End Page: 72Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2018.12.017Best OA location URL: https://repositorio.udes.edu.co/handle/001/3108Citation Count: 4
-
OPENTitle: Synthesis and characterization of a series of chiral alkoxymethyl morpholine analogs as dopamine receptor 4 (D4R) antagonistsJournal Name: Bioorganic & Medicinal Chemistry LettersPublisher: Elsevier BVVol: 26Issue #: 10Start Page: 2481End Page: 2488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bmcl.2016.03.102Best OA location URL: http://doi.org/10.1016/j.bmcl.2016.03.102Citation Count: 26
-
OPENTitle: Nurr1:RXRα heterodimer activation as monotherapy for Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 114Issue #: 15Start Page: 3999End Page: 4004Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1616874114Best OA location URL: https://www.pnas.org/content/pnas/114/15/3999.full.pdfCitation Count: 84
-
OPENTitle: A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 514Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aau6870Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7359409Citation Count: 105
-
OPENTitle: Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 22Issue #: 1Start Page: 262End Page: 262Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-022-02770-7Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-022-02770-7Citation Count: 14
-
OPENTitle: ARSA variants in α-synucleinopathiesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 142Issue #: 12Start Page: e70End Page: e70Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awz340Best OA location URL: https://academic.oup.com/brain/article-pdf/142/12/e70/31499429/awz340.pdfCitation Count: 21
-
OPENTitle: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 34Issue #: 4Start Page: 526End Page: 535Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27642Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6469643Citation Count: 114
-
OPENTitle: Epigenetic ageing and the risk of Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 97Issue #: 5Start Page: 385End Page: 392Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2025-336802Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC12915515/Citation Count: 0
-
OPENTitle: Association of Tripartite Motif Containing 11 rs564309 With Tau Pathology in Progressive Supranuclear PalsyJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 890End Page: 894Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7528208Citation Count: 10
-
OPENTitle: Contrast Acuity With Different Colors in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 6Issue #: 8Start Page: 672End Page: 677Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12821Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12821Citation Count: 7
-
OPENTitle: High-content analysis of α-synuclein aggregation and cell death in a cellular model of Parkinson's diseaseJournal Name: Journal of Neuroscience MethodsPublisher: Elsevier BVVol: 261Issue #:Start Page: 117End Page: 127Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jneumeth.2015.11.009Best OA location URL: http://linkinghub.elsevier.com/retrieve/pii/S0165-0270(15)00411-2Citation Count: 17
- Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate2020OPENTitle: Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidateJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 138Issue #:Start Page: 104789End Page: 104789Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2020.104789Best OA location URL: https://doi.org/10.1016/j.nbd.2020.104789Citation Count: 34